Lv54
1070 积分 2023-12-30 加入
Mechanistic modeling of FcRn-dependent IgG drug interactions: Clinical applications and dosing implications
10天前
已完结
Apolipoprotein E in Alzheimer’s disease trajectories and the next-generation clinical care pathway
12天前
已完结
Meta‐Analysis of Exposure‐Adverse Event Relationships for Antibody–Drug Conjugates
22天前
已完结
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
28天前
已完结
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
28天前
已完结
Antibody-drug conjugates in colorectal cancer: advances, challenges, and prospectives
29天前
已完结
Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination
29天前
已完结
Advances in Payload and Linker Designs for ADCs
29天前
已完结
Multivalent linkers: A growing trend in antibody–drug conjugate development
29天前
已完结
Dual-payload antibody–drug conjugates: Taking a dual shot
29天前
已完结
皖公网安备34019202002308
